Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -21.318% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1cc(C(=O)CSc2nnc(-c3ccc(F)cc3)o2)c(C)n1CC1CCCO1
b.) COc1cccc(OCc2cc(C(=O)N3CCN(C4CCCC4)CC3)no2)c1
Answer: b. COc1cccc(OCc2cc(C(=O)N3CCN(C4CCCC4)CC3)no2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(OCc2cc(C(=O)N3CCN(C4CCCC4)CC3)no2)c1
COc1cccc(OCc2cc(C(=O)N3CCN(C4CCCC4)CC3)no2)c1
(4-cyclopentylpiperazin-1-yl)-[5-[(3-methoxyphenoxy)methyl]-1,2-oxazol-3-yl]methanone